EZH2 and breast carcinoma: In case of mutation, LIAS can convert HIF1-α stable in non-hydroxylated form, HIFI-α activation is the basis of the abnormal functional switch of EZH2/PRC2 in breast cancer (Burr et al., 2016; Mahara et al., 2016).